ANALYST INTERVIEW: INNOVATIVE BIOPHARMACEUTICAL COMPANIES: ED GORDON - PUNK ZIEGEL & CO.(PAJ902) INNOVATIVE BIOPHARMACEUTICAL COMPANIES: ED GORDON - PUNK ZIEGEL & CO. Reviews the performance of the industry, and examines recent changes that have impacted companies in that sector. Topics discussed include competition, mergers and acquisitions, and the development of customer demand; and a number of companies are identified that are considered well positioned to succeed in the current market. Sector: Biotechnology. Published date 5/8/02. Tickers featured: ABI, ARDM, ARQL, AVE, BEC, BTRN, DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. , GLGC, GNSC GNSC Global NetOps Support Center (Defense Information Systems Agency Network Center) , IGEN, IMCL, LEXG, MEDI, MLNM, NVO NVO no visible oestrus (see no visible estrus). Called also NVE. , PFE, PGNX, TRMS, VXGN. Complete text approximately 3000 words. Document # PAJ902. ANALYST INTERVIEWS, The Wall Street Transcript, 67 Wall Street, NY 10005. Voice (212) 952 7433. Fax: (212) 668-9842. E-mail: transcript@twst.com. *** |
|
||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion